Amylyx Pharmaceuticals, Inc. (AMLX)
38.15
-0.51
(-1.32%)
USD |
NASDAQ |
Aug 24, 16:00
38.14
-0.01
(-0.03%)
After-Hours: 20:00
Amylyx Pharmaceuticals Market Cap : 4.249B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 4.249B |
| August 21, 2026 | 4.305B |
| August 20, 2026 | 4.417B |
| August 19, 2026 | 4.299B |
| August 18, 2026 | 3.910B |
| August 17, 2026 | 2.387B |
| August 14, 2026 | 2.409B |
| August 13, 2026 | 2.504B |
| August 12, 2026 | 2.600B |
| August 11, 2026 | 2.632B |
| August 10, 2026 | 2.525B |
| August 07, 2026 | 2.541B |
| August 06, 2026 | 2.694B |
| August 05, 2026 | 2.433B |
| August 04, 2026 | 2.436B |
| August 03, 2026 | 2.239B |
| July 31, 2026 | 2.255B |
| July 30, 2026 | 2.304B |
| July 29, 2026 | 2.191B |
| July 28, 2026 | 2.171B |
| July 27, 2026 | 2.164B |
| July 24, 2026 | 2.044B |
| July 23, 2026 | 1.953B |
| July 22, 2026 | 1.965B |
| July 21, 2026 | 2.054B |
| Date | Value |
|---|---|
| July 20, 2026 | 1.937B |
| July 17, 2026 | 1.971B |
| July 16, 2026 | 1.890B |
| July 15, 2026 | 1.974B |
| July 14, 2026 | 2.021B |
| July 13, 2026 | 1.933B |
| July 10, 2026 | 1.973B |
| July 09, 2026 | 2.041B |
| July 08, 2026 | 1.985B |
| July 07, 2026 | 2.017B |
| July 06, 2026 | 1.995B |
| July 02, 2026 | 2.028B |
| July 01, 2026 | 1.993B |
| June 30, 2026 | 1.994B |
| June 29, 2026 | 2.076B |
| June 26, 2026 | 1.975B |
| June 25, 2026 | 1.936B |
| June 24, 2026 | 1.887B |
| June 23, 2026 | 1.818B |
| June 22, 2026 | 1.808B |
| June 18, 2026 | 1.740B |
| June 17, 2026 | 1.693B |
| June 16, 2026 | 1.671B |
| June 15, 2026 | 1.686B |
| June 12, 2026 | 1.620B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 159.40B |
| Eli Lilly & Co. | 1.174T |
| Merck & Co., Inc. | 371.93B |
| EyePoint, Inc. | 413.86M |
| Bristol Myers Squibb Co. | 137.45B |
Market Cap Related Metrics
| Price to Book Value | 17.76 |
| Price | 38.15 |
| Earnings Yield | -3.76% |